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Abstract
Background: The D-mannose binding lectin ArtinM is known to recruit neutrophils, to degranulate mast cells and may have
potential therapeutic applications. However, the effect of ArtinM on mast cell recruitment has not been investigated.
Methodology: Male Wistar rats were injected i.p. with ArtinM or ConA (control). The ability of the lectin to degranulate
peritoneal and mesenteric mast cells was examined. Recruitment of mast cells to the peritoneal cavity and mesentery after
ArtinM injection was examined with or without depletion of peritoneal mast cells by distilled water.
Results: ArtinM degranulated both peritoneal and mesentery mast cells in vitro. Three days after i.p. injection of the lectin
there were reduced numbers of mast cells in the peritoneal lavage, while at 7 days post injection of ArtinM, the number of
peritoneal mast cells was close to control values. Since immature mast cells are recruited from the bone marrow, the effect
of the lectin on bone marrow mast cells was examined. Injection of ArtinM resulted in an increased number of mast cells in
the bone marrow. To determine if degranulation of mast cells in the peritoneal cavity was required for the increase in bone
marrow mast cells, the peritoneal cavity was depleted of mast cells with ultrapure water. Exposure to ArtinM increased the
number of mast cells in the bone marrow of rats depleted of peritoneal mast cells.
Conclusions: The ArtinM induced recruitment of mast cells from the bone marrow to the peritoneal cavity may partially
explain the therapeutic actions of ArtinM.
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Introduction
The D-mannose binding lectin, ArtinM, previously called KM+
or Artocarpin, is known modulate the immune response, activating
macrophages [1], neutrophils [2] and mast cells [3]. Previous
studies have shown that in mice, administration of ArtinM
stimulates IL-12p40 production by macrophages and dendritic
cells [1]. As a consequence ArtinM induces Th1 protective
responses against Leishmania major [1], Leishmania amazonensis [4]
and Paracoccidioides brasilensis [5]. Recently, topical treatment with
ArtinM has been shown to accelerate corneal epithelial wound
healing in rabbits [6]. Thus, ArtinM may have potential
therapeutic applications.
ArtinM is known to activate mast cells either by binding IgE
bound to the high affinity IgE receptor (FceRI) or by binding
directly to FceRI [3]. Activation of mast cells via FceRI causes the
immediate release of pre-formed mediators, the production of
newly formed lipid mediators and 8 to 12 hours after activation
the release of newly synthesized cytokines and growth factors [7,8].
Following i.p. injection of ArtinM in rats, there is recruitment of
neutrophils to the peritoneal cavity [9]. Further studies indicated
that mast cell activation provides an amplification loop for the
ArtinM induced neutrophil recruitment [3]. However, in these
studies, the effect of ArtinM on mast cell recruitment was not
investigated.
Mast cells play a role in many physiological and pathological
processes [10] including allergy, inflammation, cancer, and heart
disease, [11,7] and are also important in maintaining tissue
homeostasis [12]. They are a major source of cytokines and
chemokines giving them importance as immunoregulatory cells.
Mast cells are also critical cellular components in such processes as
wound healing [13]. At the early stages of wound healing, mast
cells liberate various mediators that recruit other cell types to the
site of injury. At the later stages, mast cells themselves are recruited
to the wound site and contribute to wound maturation and
remodeling [14,15].
Because of the potential pharmacological applications of
ArtinM, the present study was undertaken to examine the effect
of ArtinM on mast cell degranulation and recruitment in vivo in
rats. The ability of ArtinM to degranulate mast cells in the
peritoneal cavity and mesentery and the recruitment of mast cells
from the bone marrow to the peritoneal cavity were examined.
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9776The results demonstrate that ArtinM is highly efficient in
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The research was conducted in accordance with ‘‘Ethical
principles in the use of experimental animals’’ adopted by the
Brazilian College of Animal Experimentation. Experimental
protocols were approved by the Commission on Ethics on Animal
Experimentation of the Faculdade de Medicine de Ribeira ˜o Preto
(Protocol numbers 019/2005 and 152/2005). Animals were
anesthetized with ketamine 80 mg/kg plus xylazine 12 mg/kg
(Sigma-Aldrich, St. Louis, MO) prior to experimental treatment.
Purification of ArtinM
The lectin ArtinM was purified by affinity chromatography as
previously described [9]. The purity of the preparation was
analyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and the protein concentration determined
by measuring the absorbance at 280 nm.
Animals
Male Wistar rats, weighing 150 g, were obtained from the
Central Animal Facility of the Faculdade de Medicina de Ribeira ˜o
Preto. All experiments were conducted according to the guidelines
of the Faculdade de Medicina de Ribeira ˜o Preto (Protocol
numbers 019/2005 and 152/2005). Animals were anesthetized
with ketamine 80 mg/kg plus xylazine 12 mg/kg (Sigma-Aldrich,
St. Louis, MO) prior to experimental treatment. All experiments
were done in triplicate.
Cells
Peritoneal cells were obtained by injecting rats i.p. with 15 ml
PBS (phosphate buffered saline). The peritoneal washing was
collected with a Pasteur pipette after laparotomy and the cells
washed by centrifugation (x201g) in PBS prior to use. The cells
were placed on coverslips coated with Biobond (Electron
Microscopy Sciences, Hatfield, PA) fixed in 2% formaldehyde
(EM Sciences) and stained for 15 min in 0.1% Toluidine blue-1%
acetic acid, pH 2.8.
Bone marrow cells were obtained by flushing the marrow cavity
with PBS containing 2% BSA (Sigma-Aldrich), 1000 U/ml
deoxyribonuclease I (Sigma-Aldrich) and 1000 U/ml heparin
(Produtos Roche Quı ´micos e Farmace ˆuticos S.A., Rio de Janeiro,
R.J.). The marrow was dissociated by aspirating the cells with a
Pasteur pipette and passing the suspension through a 25 mm nylon
filter. The cells were washed by centrifugation (x201g) in PBS prior
to use.
Mesentery
The mesentery was removed from animals along with the
intestines and placed in Petri dishes whose bottoms were covered
with paraffin. The mesenteries were stretched over the paraffin
and secured with fine needles. The mesentery was then fixed in
10% formalin (J.T. Merck, Darmstadt, Germany) in PBS and
stained for 15 min in 0.1% Toluidine blue-1% acetic acid, pH 2.8.
Mesentery fragments were stretched over glass slides, dried on a
heating plate at 45uC, dehydrated in a graded series of ethanol
(Merck), cleared in xylene (Merck), and coverslips mounted with
Permount (Fisher Scientific, Atlanta, GA).
Treatments
Lectins. For experiments in vivo, animals were injected i.p.
with 4 ml of PBS containing either 10 mg or 200 mg ArtinM or
ConA (Sigma Aldrich, St. Louis, MO). For in vitro experiments the
peritoneal lavage or mesentery fragments were incubated in 1 ml
Iscove’s Modified Dulbecco’s Medium (Sigma-Aldrich) containing
10 mg or 200 mg of ArtinM or ConA at 30uC for 1 h. The lectin
concentrations chosen were based on data in the literature [3,16]
as well as on preliminary dose-response experiments. For some
experiments, the lectins were preincubated with D-galactose
(25 mM; Sigma-Aldrich), D-glucose (25 mM; Sigma-Aldrich), D-
mannose (25 mM; Sigma-Aldrich) or mannotriose (Mana1-
3[Mana1-6]Man (10 mM; Dextra Laboratories, Reading, UK).
Control animals were injected i.p. with 4 ml PBS.
Mast cell depletion of the peritoneal cavity. Mast cell
depletion of the peritoneal cavity by distilled (ultrapure) water is a
widely used method [17–19]. Although all cells types in the
peritoneal cavity are exposed to distilled water, only the mast cells,
because of their granule composition, are lysed by distilled water
[20]. In order to deplete the peritoneal cavity of mast cells, animals
were injected with 15 ml i.p. of ultrapure, sterile water (Milli-Q;
Millipore, Billerica, MA).
Mast cell degranulation. Animals were injected i.p. with
200 mg of Compound 48/80 (Sigma-Aldrich) (50 mg/ml) in 4 ml
of 0.02 M Tyrode-Tris buffer, pH 7.2 [21].
Repopulation of the mesentery. Repopulation of the
mesentery by mast cells was examined in animals with or
without depletion of the peritoneal mast cells. In animals not
depleted of peritoneal mast cells, 10 mg or 200 mg of ConA in 4 ml
PBS was injected i.p. Seven days later, the mesentery was
removed, fixed in 2% formaldehyde (EM Sciences), and stained
for 15 min in 0.1% Toluidine blue-1% acetic acid, pH 2.8.
Control animals received only PBS. Animals depleted of mast cells
by ultrapure water received 10 mg ConA or 10 mg ArtinM in 4 ml
PBS i.p. 24 h after injection of the water. Control animals received
only ultrapure water. Seven days after injection of the lectins, the
mesentery was removed, fixed in 2% formaldehyde (EM Sciences),
and stained for 15 min in 0.1% Toluidine blue-1% acetic acid,
pH 2.8.
In vitro degranulation assays. For in vitro degranulation
assays, prior to fixation, mesentery fragments were incubated with
10 mg/ml of either lectin. Controls were incubated in medium
without lectin. After incubation, the fragments were rapidly
washed in PBS, fixed in 2% formaldehyde (EM Sciences) and,
stained for 15 min in 0.1% Toluidine blue-1% acetic acid, pH 2.8.
Quantification of peritoneal and mesenteric mast cells
Images were acquired by bright field microscopy with a 40X
objective using a Nikon Eclipse E800 microscope (Nikon USA,
Melville, NY) equipped with a Nikon DXM1200 digital camera.
Images from 10 (peritoneal lavage) or 16 (mesentery) separate
fields from 3 separate rats for each experimental condition were
acquired. All fields of the mesentery included a mesenteric blood
vessel. For the peritoneal lavage, the number of granulated and
degranulated mast cells in each field was determined. For the
mesentery the number of mature and immature mast cells, based
on degree of metachromasia, was analyzed.
Immunomagnetic isolation of mast cells
Tosyl activated Dynabeads (Invitrogen, Dynal Biotech, Carls-
bad, CA) were conjugated with mAb AA4, that recognizes unique
gangliosides on the surface of granulated rodent mast cells [22,23],
or with normal mouse IgG (Jackson ImmunoResearch, West
Grove, PA) as previously described [24]. Briefly, mAb AA4
ArtinM Recruits Mast Cells
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mixed with tosylactivated Dynabeads. The solution of mAb AA4
was incubated for 24 h at 22uC with slow end-over-end rotation.
After incubation the Dynabeads were collected with a magnetic
particle concentrator (MPC; Dynal). The coated beads were then
washed, using the MPC, and collected with the MPC, the
supernatant discarded, and the beads resuspended in PBS
containing 0.1% BSA to a concentration of 30 mg/ml and stored
at 4uC until use. Normal mouse IgG was coupled to tosylactivated
Dynabeads using the protocol for cell separation applications as
recommended by the manufacturer.
Mast cells were immunomagnetically isolated from the
peritoneal lavage and from the bone marrow using mAb AA4
coupled to tosylactivated Dynabeads M-450 as previously
described [25,26]. After isolation, the cells were rinsed in PBS,
fixed in 2% formaldehyde (EM Sciences), and stained for 15 min
in 0.1% Toluidine blue-1% acetic acid, pH 2.8.
The percentage of mast cells was determined by counting the
cells using a Neubauer Camera. Cells attached to the magnetic
beads (positive population) as well as the negative population were
counted.
Infusion of CellTracker labeled cells
After immunomagnetic isolation, bone-marrow derived mast
cells were incubated for 30 min at 37uC in Iscove’s Modified
Dulbecco’s Medium without serum containing CellTracker Red
CMTPX (Invitrogen, Molecular Probes, Carlsbad, CA). After
labeling, the cells were incubated for an additional 30 min at 37uC
in Iscove’s Modified Dulbecco’s Medium with 10% heat
inactivated fetal bovine serum (Invitrogen, GIBCO, Carlsbad,
CA). Cell labeling was monitored by fluorescence microscopy
using a Nikon Eclipse E800 fluorescent microscope.
Before the infusion of CellTracker labeled cells, the peritoneal
cavity was depleted of mast cells by i.p. injection of 15 ml of
purified water. Then, 2.5610
5 cells/rat, labeled with CellTracker
Red CMTPX in 500 ml Iscove’s Modified Dulbecco’s Medium
were injected via the caudal vein. Control animals were injected
with only 500 ml Iscove’s Modified Dulbecco’s Medium. Two
hours after cell infusion, some animals received i.p. 10 mg ArtinM
in 4 ml PBS. Control animals received only PBS. At 24 h and
48 h after cell infusion, cells were collected from the peritoneal
cavity by laparotomy using a Pasteur pipette after injecting 15 ml
PBS into the cavity. Cells were also collected from the bone
marrow as described above. The cells were rinsed by centrifuga-
tion 5 times in PBS, fixed with 1% formaldehyde (Electron
Microscopy Sciences, Hatfield, PA) and analyzed by flow
cytometry (BD FACSCalibur
TM, BD Biosciences, Franklin Lakes,
NJ).
Statistical Analysis
The experimental results were analyzed using non paired
Student’s t-test. Differences were considered significant at *p#0.05
and **p#0.01.
Results
In the present study the ability of ArtinM to recruit mast cells
from the bone marrow to the peritoneal cavity of rats was
examined. In order to determine if mast cell recruitment was due
solely to lectin induced degranulation of peritoneal mast cells, the
effect of ArtinM was also examined in a model system in which the
peritoneal cavity was depleted of mast cells prior to administration
of the lectin. The specificity of the effects of ArtinM was analyzed
by comparing the results with ArtinM to those with ConA. ConA,
a glucose/mannose binding lectin, is well characterized for its
ability to degranulate mast cells [8,27–29].
The lectin ArtinM degranulates peritoneal and
mesenteric mast cells
In order to examine the effect of the lectin ArtinM on mast cell
degranulation, the total cell population from the peritoneal lavage
was incubated with ArtinM or ConA. After staining with toluidine
blue, the preparation was examined by bright field microscopy
and the percent of degranulated mast cells was determined.
Incubation with 10 mg/ml of either ArtinM or ConA (Fig. 1A and
B) resulted in degranulation of 75%65.7% and 85%61.1%,
respectively, of peritoneal mast cells in vitro. Incubation with PBS
did not elicit degranulation (Fig. 1C) and incubation with
Compound 48/80 resulted in virtually 100% degranulation
(Fig. 1D). In order to determine if this degranulation was
dependent on the carbohydrate recognition domain (CRD) of
the lectins, the lectins were assayed following preincubation with
various sugars. Mast cell degranulation was inhibited only by the
lectin specific sugars (Fig. 1E). When ArtinM was preincubated
with 25 mM D-mannose or 10 mM mannotriose, only
34.460.9% and 16.764.8% respectively of the mast cells were
degranulated. When ConA was preincubated with 25 mM D-
glucose or 25 mM D-mannose only 25.6610.9% and 26.166.4%
respectively of the mast cells were degranulated.
The effect of ArtinM and ConA on peritoneal mast cell
degranulation in vivo was examined by injecting rats i.p. with either
lectin. At 10 mg/rat only ArtinM resulted in mast cell degranu-
lation (Fig. 2). However at a higher concentration (200 mg/rat),
both lectins degranulated peritoneal mast cells to the same extent.
These results demonstrate that the lectins ConA and ArtinM have
the ability to degranulate peritoneal mast cells in vivo as well as in
vitro.
In order to determine if the lectins ArtinM and ConA could also
degranulate mesenteric mast cells, mesenteric fragments were
incubated with 10 mg/ml of each lectin. Neither lectin induced
mast cell degranulation (Fig. 3A and B) at this concentration.
However, when the mesenteric fragments were incubated with the
lectins at 200 mg/ml mast cell degranulation was observed (Fig. 3C
and D). The percent of cells degranulated, 27.4%62.3% of the
mesenteric mast cells incubated with ArtinM and 32.2%62.9% of
the mesenteric mast cells incubated with ConA, was significantly
greater than mesenteric mast cells incubated only with PBS
(Fig. 3E). Although both lectins have the ability to degranulate
mast cells, higher concentrations of the lectins are needed to
degranulate mast cells in the mesentery. This is presumably due to
the fact that the lectins also bind to the extracellular matrix
surrounding the mesenteric mast cells thus reducing the amount of
lectin available to bind to the mast cells.
The ability to degranulate mesenteric mast cells in vivo appeared
to be dose dependent. In order to determine if this dose
dependency is related to the binding of lectin to the extracellular
matrix, animals were injected with 10 mg/ml or 200 mg/ml (4 ml/
animal) of Con A conjugated to FITC. At a concentration of
10 mg/ml of Con A there was only a faint labeling of the
extracellular matrix and none of the mast cells were labeled
(Fig. 4A and B.). However, after IP injection of 4 ml of 200 mg/ml
of Con A conjugated to FITC, the lectin bound strongly to the
fibers in the extracelular matrix and mast cells were labeled
(Fig. 4C and D). These results indicate that in vivo at low
concentrations there is not sufficient lectin available to bind
directly to the mast cells. It is also possible that at high
concentrations, the lectin persists in the peritoneal cavity for a
longer time.
ArtinM Recruits Mast Cells
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reduction in the number of metachromatic peritoneal
mast cells
The number of metachromatic mast cells was examined in the
peritoneal lavage at 3 and 7 days after i.p. injection of the lectins.
At 3 days post stimulation, released granule matrix has been
cleared from the peritoneal cavity and secretory granule
resynthesis is complete [21]. When the peritoneal lavage was
examined 3 days after i.p. injection of 10 mg ArtinM, there was a
32%60.3% reduction in the number of metachromatic mast cells.
By 7 days the percent of metachromatic peritoneal mast cells was
almost the same as that seen in the control animals (Fig. 5). IP
injection of 200 mg of ArtinM was no more effective in reducing
the mast cell number than 10 mg ArtinM. In contrast, after i.p.
injection of 10 mg ConA, the number of metachromatic peritoneal
mast cells had diminished by 21.8%60.8% and by 7 days was
reduced by 32%61.3% (Fig. 5). However, when animals were
injected with 200 mg/ml of ConA at 3 days, the percent of
metachromatic mast cell dropped by 80%60.6% in comparison
with the control cells, and by day 7 the percent of mast cells was
reduced by 40%61.1% of the control values. High concentrations
of ConA had a more pronounced effect on the mast cell numbers
than increased concentrations of ArtinM. The reduction in the
number of metachromatic peritoneal mast cells seen at 3 and 7
days post injection, most likely represents a combination of the
direct effect of the lectins on mast cells and the indirect effects
mediated by the action of ArtinM on other cells, such as
neutrophils [2].
IP injection of ConA, but not ArtinM results in an
increased number of immature mast cells in the
mesentery
Seven days after injection of the lectins, when mature and
immature mast cells can be identified by their degree of
metachromasia, the mesenteries from animals injected with either
10 mg or 200 mg of ArtinM were examined. The total mast cell
number was similar to that seen in non injected animals and the
numbers of mature and immature mast cells were unaltered
(Fig. 6C). In contrast, animals injected with 10 mg or 200 mg ConA
showed an increase in the total number of mast cells in the
mesentery (Fig. 6C). Based on the degree of metachromasia,
following injection of ConA, the number of immature mast cells
Figure 1. ArtinM and ConA degranulate peritoneal mast cells in
vitro in a lectin specific manner. The total cell population from the
peritoneal lavage was incubated with 10 mg of ArtinM (A) or ConA (B).
Control cells were incubated in PBS (C). Compound 48/80 (D) was used
as a positive control for degranulation. Stained with Toluidine blue.
(Arrows, degranulated mast cells; Asterisks, intact mast cells)
Bars=10 mm. Quantification of peritoneal mast cell degranulation (E).
The data shown is the average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g001
Figure 2. ArtinM and Con A also degranulate mast cells in vivo.
The peritoneal lavage was examined 1 hr after i.p. injection of 10 mgo f
either lectin. There was no significant difference in the ability the two
lectins to degranulate mast cells. **p#0.01. The data shown is the
average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g002
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10 mg/ml ArtinM (A), 10 mg/ml ConA (B), 200 mg/ml ArtinM (C) or 200 mg/ml ConA (D). (Arrows, degranulated mast cells; *, non degranulated mast
cells). Bar=20 mm. Inset (C): Details of degranulated mast cell indicated by arrowhead. Bar=10 mm Stain: Toluidine blue. Quantification of mesenteric
mast cell degranulation by ArtinM or ConA (E). At 200 mg of either ArtinM or ConA there was significant (**p#0.01) degranulation of mesenteric mast
cells. The data shown is the average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g003
ArtinM Recruits Mast Cells
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3 times the number seen in the PBS injected animals (Fig. 6B).
However, the number of mature mast cells was unaltered. These
results suggest that in the presence of ConA, mast cell
degranulation may not be necessary for recruitment of immature
mast cells and that ConA may be acting as a chemotactic factor.
IP injection of ArtinM or ConA results in an increase in
the number of mast cells in the bone marrow
Since repopulation of mast cells at peripheral sites is thought to
occur by recruitment of bone marrow mast cells [26,30], it was of
interest to investigate the changes in the number of bone marrow
mast cells (Figure 7). Mast cells were immunomagnetically isolated
from the bone marrow using mAb AA4 conjugated to magnetic
beads. mAb AA4 recognizes mast cell specific gangliosides on the
surface of very immature, immature and mature rodent mast cells
(granulated mast cells). Three days after i.p. injection of 10 mgo f
ArtinM there was no difference in the number of bone marrow
mast cells as compared to animals injected with only PBS.
However, by 7 days after injection there was a 456%60.6%
increase in mast cells in the bone marrow. With 200 mg of ArtinM
at 3 days there was an increase of 10260.2% in bone marrow
mast cells and by 7 days the number had increased to
124%60.2% (Fig. 7). The same experiments were repeated using
ConA. Although at 3 days after i.p. injection of 10 mg ConA, there
was no significant change in the percent of mast cells present in the
bone marrow, by 7 days there was a 115%60.4% increase in the
mast cells in comparison to PBS injected controls. In contrast, 3
days after i.p. injection of 200 mg ConA there was a 38%60.4%
increase in the percent of bone marrow mast cells and after 7 days
the percent had increased to 172%60.1% in comparison to
controls. Therefore, at 7 days post injection of either ArtinM or
ConA the percentage of mast cells in the bone marrow was
dramatically increased. Furthermore, 10 mg ArtinM was most
effective in increasing the mast cell population in the bone
marrow. These data suggest that the effects of i.p. lectin injection
extend beyond the peritoneal cavity and also affect mast cells in
the bone marrow.
ArtinM is efficient in recruiting mast cells to the
peritoneal cavity and to the mesentery in animals
depleted of peritoneal mast cells
In order to investigate the contribution of peritoneal mast cells
in the recruitment of mast cells following ArtinM, animals were
injected i.p. with ultrapure water to deplete the peritoneal cavity
and the mesentery of mast cells [17,20]. Twenty-four hours later,
animals were injected i.p. with ArtinM or ConA (10 mg/rat) and 7
days after lectin injection, the peritoneal lavage and mesentery
were collected and the mast cells quantified (Fig. 8A). At this time
repopulation of the peritoneal cavity is underway and immature
and mature mast cells can be identified by their metachromasia
[18]. Under these conditions, ArtinM is effective in recruiting mast
cells to the peritoneal cavity (Fig. 8B). In comparison to the non-
depleted animals, which had 24.1% mast cells in the peritoneal
lavage, animals injected with water only had 5.1%61.0% mast
cells in the peritoneal lavage. In contrast, animals injected with
ArtinM had twice the percentage of peritoneal mast cells in
comparison with animals injected only with water and 15 times the
percentage of mast cells in comparison with animals injected with
ConA. In animals injected with ConA, the percentage of
peritoneal mast cells was significantly lower (0.7%60.2%) in
comparison to the animals injected only with water or with
ArtinM.
Intraperitoneal injection of with ultrapure water is also efficient
in depleting the mesentery of mast cells (Fig. 9) [17,20]. Twenty
four hours after i.p. injection of purified water, no mast cells were
present in the mesentery (Fig. 9B), but by 8 days after water
injection, the total number of mast cells was returning to normal
(Fig. 9C). However in comparison to non depleted animals, the
water injected animals had significantly more immature mast cells
than mature mast cells. In contrast, following i.p. injection of
ArtinM into depleted animals the total number of mast cell was 1.8
times that seen in non depleted animals and 2.2 times greater than
in the animals that received water only. This difference was largely
due to increased numbers (883.5675.7) of mature mast cells and
there was no significant difference between the number of
immature mast cells seen in depleted animals injected with
Figure 4. Con A-FITC binds preferentially to the extracellular
matrix. Rats were injected i.p. with 10 mg Con A-FITC (A. Fluorescence
image, B. DIC image) or with 200 mg Con A-FITC. (C. Fluorescence
image, D. DIC image). (Mast cells, arrows).
doi:10.1371/journal.pone.0009776.g004
Figure 5. Intraperitoneal injection of ArtinM and ConA reduces
the percentage of metachromatic mast cells in the peritoneal
lavage. Animals were injected i.p. with 4 ml of PBS containing either
10 mg or 200 mg of ArtinM or ConA, and the percent of metachromatic
mast cells present in the peritoneal lavage was examined at 3 and 7
days post injection. The results shown are the average6SD of 3
separate experiments. 3 days post injection: &; 7 days post injection:
%.* p#0.05, **p#0.01.
doi:10.1371/journal.pone.0009776.g005
ArtinM Recruits Mast Cells
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1.5 times increase in the total number of mast cells as compared
with animals injected with water only. This increase in total mast
cell number was due to a preferential increase in the number
(588.5616.3) of mature mast cells, in relation to the number
(109618.4) of mature mast cells seen in animals injected only with
water. This was accompanied by a reduction in the number
(44.567.8) of immature mast cells. In the absence of mast cells in
the peritoneal cavity, both lectins were efficient in recruiting mast
cells to the peritoneal cavity and the mesentery, although ArtinM
was considerably more effective. In addition, the lectins, especially
ArtinM, appeared to accelerate mast cell maturation. These data
further indicate that degranulation of peritoneal mast cells by the
lectins is not essential for mast cell recruitment.
IP injection of ArtinM results in an increase in the number
of mast cells in the bone marrow of rats depleted of
peritoneal mast cells
Since mast cells were recruited to the peritoneal cavity following
injection of ArtinM or ConA, the effect of lectin administration on
mast cell numbers in the bone marrow following mast cell
depletion in the peritoneal cavity was also assessed. Animals were
injected i.p. with ultrapure water. Twenty-four hours later,
animals were injected i.p. with ArtinM or ConA (10 mg/rat) and
7 days after lectin injection, mast cells were isolated immuno-
magnetically from the bone marrow using mAb AA4 (Fig. 10). In
the non-depleted animals 2.560.4% of the bone marrow cells
were mast cells. At 8 days after ultrapure water, all of the depleted
animals had significantly reduced numbers of mast cells in the
bone marrow in comparison to the non-depleted controls. In
animals that received only water the percent of mast cells was
reduced to 0.4%60.04%. However, the depleted animals that had
been injected with ArtinM had 3 times as many mast cells
(1.5360.1%) as the depleted animals that had not received the
lectin and in the animals injected with ConA the percentage was
only 1.1860.2% (Fig. 10). These results indicate that the lectins
may have an indirect effect by increasing the number of mast cells
in the bone marrow, thus providing a source of mast cells for
repopulation of the peritoneal cavity.
ArtinM augmented the homing of infused bone marrow
derived mast cells to the peritoneal cavity
In order to further investigate if bone marrow mast cells are
involved in the ArtinM induced mast cell repopulation of the
peritoneal cavity, mast cells were isolated from the bone marrow,
labeled with CellTracker
TM, and infused into animals whose
Figure 6. ConA, but not ArtinM recruits immature mast cells to the mesentery. In the mesentery, 7 days after i.p. injection of 200 mg of Con
A immature mast cells (arrows) with few metachromatic granules as well as mature mast cells (*) were found next to a blood vessel (A). In animals
injected with PBS, only mature mast cells (*) were seen along blood vessels (B). Stain: Toluidine blue. (C) Seven days after i.p. injection of 10 mgo r
200 mg of ArtinM or ConA the total number of mesenteric mast cells as well as the number of mature and immature mast cells was determined.
*p#0.05. The results shown are the average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g006
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control animals a small number of these bone marrow derived
mast cells homed to the peritoneal cavity. Injection of ArtinM, i.p.,
increased the homing 18 fold. These results further confirm the
role of ArtinM as a chemoattractant for mast cells.
Discussion
The present study demonstrates that following i.p. injection of
the lectins ArtinM and ConA mast cells are recruited from the
bone marrow to the peritoneal cavity and mesentery in rats,
indicating that local administration of lectin may have conse-
quences at distant sites. I.p. injection of the lectins also results in
increased numbers of mast cells in the bone marrow that could be
serving as a source of mast cells in order to repopulate the
peritoneal cavity. This investigation further shows that ArtinM was
more efficient than ConA in recruiting mast cells to the peritoneal
cavity and more effective in increasing the number of mast cells in
the bone marrow, suggesting that the overall response may be
specific to a given lectin.
Exposure to ArtinM and ConA results in peritoneal mast cell
degranulation at both low (10 mg) and high doses (200 mg) while
mesentery mast cells degranulate only at high concentrations. The
higher doses of lectin required for degranulation of mesenteric
mast cells may be due to the fact that the lectins bind to the
extracellular matrix surrounding the mast cells, thus lowering their
Figure 7. Intraperitoneal injection of lectin increases the
percent of mast cells in the bone marrow. Animals were injected
i.p. with Artin M or ConA. At 3 (&)o r7( %) days after injection mast
cells were immunomagnetically isolated from the bone marrow using
mAb AA4 and the percent of mast cells determined. *p#0.05. The
results shown are the average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g007
Figure 8. ArtinM recruits mast cells to the peritoneal cavity in
mast cell depleted animals. Animals were injected i.p. with purified
water to deplete the peritoneal cavity of mast cells and 24 h later
received an i.p. injection of 4 ml of PBS containing 10 mg of ArtinM or
ConA. The peritoneal lavage was collected 7 days after lectin injection
(A). The percent of peritoneal mast cells was determined under the
various conditions (B). *p#0.05. The results shown are the average6SD
of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g008
Figure 9. Intraperitoneal lectin injection recruits mast cells to
the mesentery in mast cell depleted animals. Animals were
injected i.p. with purified water to deplete the peritoneal cavity of mast
cells and 24 h later received an i.p. injection containing 10 mg of ArtinM
or ConA. The mesentery was collected 7 days after lectin injection. In
uninjected animals (A) the mesentery was replete with mature mast
cells. Many lying adjacent to blood vessels (V). Twenty four hours after
injection of purified water (B) no mast cells could be seen in the
mesentery. The total number of mesenteric mast cells as well as the
number of mature and immature mesenteric mast cells was determined
under the various conditions (C). *p#0.05. The results shown are the
average6SD of 3 separate experiments.
doi:10.1371/journal.pone.0009776.g009
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previous observations concerning mast cell degranulation induced
by ArtinM [3], ConA [27,30,31] and by other mannose/glucose-
binding lectins [32]. They are also similar to the results seen with
lectins that have specificities other than mannose and mannose/
glucose, such as the GalNAc-binding lectin from Dolichos biflorus
[33]and the chitin-binding lectin from Solanum tuberosus [34].
However, the mast cell degranulation induced by these lectins is
attributed to its binding to oligosaccharides linked to IgE, whereas
ArtinM causes degranulation of RBL-2H3 cells whether or not the
cells have IgE bound to FceRI [3], suggesting that ArtinM may be
interacting with mannose containing glycans on FceRI itself.
Analysis of the structure and composition of FceRI in RBL-2H3
cells found that carbohydrates comprise 32% of the receptor [35].
Among the sugars present are galactose, manose, glycosamine and
fucose. The extracellular domain of the a subunit in humans, that
binds IgE, has 7 possible N-glycosylation sites while the a subunit
of FceRI in mice and rats has 6 and 7 potential N-glycosylation
sites respectively. Thus, it is probable that contiguous IgE
receptors are cross-linked by tetrameric ArtinM in vivo.
The increased numbers of mast cells in the bone marrow 7 days
after treatment with ArtinM and to a lesser extent with ConA
indicate that i.p. injection of these lectins is stimulating mast cell
proliferation in the bone marrow. The bone marrow serves as a
reservoir of immature mast cells that can be recruited to peripheral
sites [25,26]. This was confirmed in the present study by the
increase in bone marrow derived mast cells that homed to the
peritoneal cavity following ArtinM administration. Interaction
between soluble or membrane bound lectins and cells from the
immune system can activate these cells [36–38]. Among the
processes that may be stimulated by exposure to lectins is cell
proliferation. Although little is known about the ability of lectins to
induce mast cell proliferation, a wide variety of lectins have been
shown to be mitogenic for various other cell types [39,40].
Therefore, it would be reasonable to expect that ArtinM would
also stimulate mast cell proliferation. Preliminary studies in our
laboratory have shown that ArtinM can stimulate mast cell
proliferation at concentrations below those needed for degranu-
lation. This fact may also explain the ability of ArtinM to act as a
therapeutic agent [4,6] without eliciting an allergic response.
The migration of mast cells is important in many different
processes such as inflammation, allergy, tissue repair and
tumorigenesis [30,41]. The ability of any plant lectin to recruit
mast cells has not been reported. In this study, we showed that
ArtinM and ConA were efficient in recruiting mast cells from the
bone marrow after i.p injection of the lectins in non-depleted
animals. In analogy with leukocyte recruitment this suggests that
soluble chemoattractants may act jointly with adhesion molecules
to regulate the homing of immature mast cells to tissues [16].
These chemoattractants may also be involved in the release of
progenitors from the bone marrow. Plant lectins that bind to
mannose or galactose may interact with various endogenous
molecules involved in innate and acquired immune responses.
There are several published studies indicating that some plant
lectins may mimic endogenous lectins in animals and induce
migration of neutrophils and mononuclear cells in vitro and in vivo
[9,42]. During cell migration, the cells interact with their
surrounding environment by means of cell-cell interactions or
cell-matrix interactions [43–47]. Mast cell migration induced by
ArtinM may occur by a process similar to that reported for
neutrophils. Santos-de-Oliveira [9] showed that ArtinM induces
migration of neutrophils to the peritoneal cavity or air pouch of
rats and also showed that ArtinM has chemotactic activity for
human neutrophils in vitro. The attraction occurs by haptotaxis
rather than chemotaxis. The hemagglutination activity of ArtinM
as well as its inhibition by carbohydrates (D-manose, D-glucose, or
a-methyl-D-mannoside) suggests that ArtinM has at least two
carbohydrate binding sites. One of the two binding sites may
interact with carbohydrates on the neutrophil surface, and the
other site binds to glycoconjugates in the extracellular matrix. The
binding of ArtinM to the extracellular matrix results in a lectin
Figure 10. Intraperitoneal Injection of either ArtinM or ConA
resulted in a significant increase in the percent of mast cells in
the bone marrow. Eight days after injection of water and 7 days after
injection of 10 mg of ArtinM or ConA, mast cells were immunomagne-
tically isolated from the bone marrow with mAb AA4 conjugated
magnetic beads. **p#0,01. The results shown are the average6SD of 3
separate experiments.
doi:10.1371/journal.pone.0009776.g010
Figure 11. ArtinM increases the number of bone marrow
derived mast cells recruited to the peritoneal cavity. The
peritoneal cavity was depleted of mast cells by injection of ultrapure
water prior to the infusion of immunomagnetically isolated bone
marrow derived mast cells labeled with CellTracker Red CMTPX
TM and i.p.
injection of ArtinM. At 24 and 48 h after infusion, the presence of
fluorescently labeled mast cells in the peritoneal lavage was analysed
by FACS. Each data point represents the average number of cells6S.D.
from 3 separate experiments. 100,000 cells were counted per time point
in each experiment. (& with ArtinM; % without ArtinM).
doi:10.1371/journal.pone.0009776.g011
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ArtinM gradient can then induce the binding and the haptotactic
migration of neutrophils through the blood vessels. A similar
process may be occurring during ArtinM induced mast cell
migration.
The interaction of mast cells with lectins has been studied in vitro
[3], but almost nothing has been done in vivo due to the lack of
mast cell markers. The results of this study showed that ArtinM
stimulated mast cell migration and resulted in an increase in
mature and immature mast cells in the bone marrow. Because the
mechanisms underlying mast cell recruitment to peripheral sites
are poorly understood, ArtinM may be an important tool for
elucidating the molecular mechanisms involved in recruitment and
migration of mast cells as well as other hematopoietic cells.
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